Metadoxil (Metadoxine)

Metadoxine, the active ingredient in Metadoxil, is a hepatoprotective agent presented as an oral formulation for oral use. It is used to support liver function in conditions such as alcoholic liver disease, hepatic steatosis and other forms of liver dysfunction.

GNH USA supplies Metadoxil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metadoxil acts on hepatic metabolic pathways to protect liver cells and improve liver function. - Alcoholic liver disease: helps reduce liver inflammation and supports recovery of liver function. - Hepatic steatosis: assists in decreasing fat accumulation in liver cells. - Liver dysfunction: contributes to overall hepatic protection and metabolic balance.

Metadoxil may be associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Gastrointestinal discomfort: abdominal pain or dyspepsia. - Fatigue: feeling of tiredness. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hepatic failure: worsening liver function tests. - Neutropenia: low white blood cell count. - Thrombocytopenia: reduced platelet count. - Acute pancreatitis: abdominal pain with elevated enzymes. - Anaphylaxis: rapid onset of systemic allergic response.

Use of Metadoxil requires careful clinical consideration. - Monitor liver function: regular blood tests to assess hepatic enzymes. - Avoid alcohol: concurrent intake may counteract therapeutic benefit. - Caution in renal impairment: adjust use if kidney function is reduced. - Pregnancy and lactation: safety not established; use only if clearly needed. - Pediatric use: not recommended without specialist guidance. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Metadoxil can interact with several medications and substances.

Major Interactions (Avoid): - Alcohol: may exacerbate liver toxicity. - Strong hepatotoxic drugs (e.g., high‑dose acetaminophen): increase risk of liver injury. - MAO inhibitors: potential for unpredictable metabolic effects.

Moderate Interactions (Monitor Closely): - Statins: monitor liver enzymes for additive hepatotoxicity. - Anticoagulants (warfarin): watch for altered coagulation parameters. - Antihypertensives: possible changes in blood pressure control. - Antidiabetic agents: monitor glucose levels for variability. - Herbal supplements (e.g., kava, valerian): assess for combined sedative effects.